# Safety and Efficacy of Veronate® Versus Placebo in Preventing Nosocomial Staphylococcal Sepsis in Premature Infants

> **NCT00113191** · NA · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 2000 (—)

## Conditions studied

- Nosocomial Infections
- Sepsis
- Staphylococcal Infections
- Candidemia

## Interventions

- **DRUG:** Veronate

## Key facts

- **NCT ID:** NCT00113191
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-05
- **Primary completion:** 2006-06
- **Final completion:** 2006-06
- **Target enrollment:** 2000 (—)
- **Last updated:** 2012-08-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00113191

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00113191, "Safety and Efficacy of Veronate® Versus Placebo in Preventing Nosocomial Staphylococcal Sepsis in Premature Infants". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00113191. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*